Market Overview - The medical services sector experienced a decline of 2.41% on November 4, with Baicheng Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3960.19, down 0.41%, while the Shenzhen Component Index closed at 13175.22, down 1.71% [1] Stock Performance - Baicheng Pharmaceutical saw a significant drop of 10.78%, closing at 61.55, with a trading volume of 296,700 shares and a transaction value of 2.041 billion [2] - Other notable declines included: - Nanmo Bio down 5.17% to 46.20 - MediX down 4.85% to 66.33 - Zhaoyan New Drug down 4.81% to 34.44 [2] Capital Flow - The medical services sector experienced a net outflow of 2.192 billion from institutional investors, while retail investors saw a net inflow of 1.581 billion [2] - The table of capital flow indicates that: - Chengda Pharmaceutical had a net inflow of 15.598 million from institutional investors [3] - New Mileage had a net inflow of 5.4082 million from retail investors [3]
医疗服务板块11月4日跌2.41%，百诚医药领跌，主力资金净流出21.92亿元